Real-time telomerase assay of less-invasively collected esophageal cell samples

Cancer Letters

Volumn 244, Issue 1, 2006, Pages 91-100

  McGruder, Brenna M ^a   Atha, Donald H ^a   Wang, Wendy ^b   Huppi, Konrad ^b   Wei, Wen Qiang ^c   Abnet, Christian C ^b   Qiao, You Lin ^c   Dawsey, Sanford M ^b   Taylor, Philip R ^b   Jakupciak, John P ^a  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CANCER HOSPITAL   (China)

Author keywords

Biomarkers; Diagnostics; Esophageal balloon cytology; Esophageal squamous cell carcinoma; Real time TRAP; Telomerase activity; Telomerase candidate reference material

Indexed keywords

BIOLOGICAL MARKER; TELOMERASE;

ACCURACY; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME ASSAY; EPITHELIUM CELL; ESOPHAGUS; FEASIBILITY STUDY; HIGH RISK POPULATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SQUAMOUS EPITHELIUM; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; CLINICAL ENZYME TESTS; CYTODIAGNOSIS; ELECTROPHORESIS, CAPILLARY; ENZYME TESTS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 33749242235     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.12.012     Document Type: Article

References (41)

1. Sidransky D. Emerging molecular markers of cancer. Nat. Rev. 2 (2002) 210-219
2. Hiyama E., and Hiyama K. Clinical utility of telomerase in cancer. Oncogene 21 (2002) 643-649
3. Etzioni R., Urban N., Ramsey S., McIntosh M., Schwartz S., Reid B., et al. The case for early detection. Nat. Rev. 3 (2003) 1-9
4. In: Joy J.E., Penhoet E.E., and Petitti D.B. (Eds). Saving women's lives: strategies for improving breast cancer detection and diagnosis (2005), The National Academies Press, Washington, DC 155-187
5. Meeker A.K., and Coffey D.S. Telomerase, a promising marker of biological immortality of germ, stem, and cancer cells. Biochemistry 62 (1997) 1323-1331
6. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
7. Shay J.W., and Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33 (1997) 787-791
8. Arai T., Yasuda Y., Takaya T., Ito Y., Hayakawa K., Toshima S., et al. Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid. Oncol. Rep. 5 (1998) 405-408
9. Asai A., Kiyozuka Y., Yoshida R., Fujii T., Hioki K., and Tsubura A. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs. Anticancer Res. 18 (1998) 1465-1472
10. Engelhardt M., Drullinsky P., Guillem J., and Moore M. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res. 11 (1997) 1931-1941
11. Dome J.S., Chung S., Bergemann T., Umbricht C.B., Saji M., Carey L.A., et al. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilm' tumor. Cancer Res. 59 (1999) 4301-4307
12. Zhang Y.I., Zhang A.S., Wu B.P., and Zhou D.Y. Early diagnosis for colorectal cancer in China. World J. Gastroenterol. 8 (2002) 21-25
13. Qin L.Z., and Tang Z.Y. The prognostic molecular marker in hepatocellular carcinoma. World J. Gastroenterol. 8 (2002) 385-392
14. Broccoli D., Young J.W., and de Lange T. Telomerase activity in normal and malignant hemotopoietic cells. Proc. Natl Acad. Sci. USA 92 (1995) 9082-9086
15. Smith L.L., Coller H.A., and Roberts J.M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5 (2003) 474-479
16. Shay J.W. Meeting Report; the role of telomeres and telomerase in cancer. Cancer Res. 65 (2005) 3513-3517
17. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000; the global picture. Eur. J. Cancer 37 Suppl. 8 (2001) S4-S66
18. Wang G.Q., Abnet C.C., Shen Q., Lewin K.J., Sun X.D., Roth M.J., et al. Histo Histologic precursors of esophageal squamous cell carcinoma: results from a 13-year prospective follow-up study in a high-risk population. Gut 54 (2005) 187-192
19. Dawsey S.M., Fleischer D.E., Wang G.Q., Zhou B., Kidwell J.A., Lu N., et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 83 (1998) 220-231
20. Roth M.J., Liu S.F., Dawsey S.M., Zhou B., Copeland C., Wang G.Q., et al. Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer 80 (1997) 2047-2059
21. Yu H.P., Xu S.Q., Lu W.H., Li Y.Y., Li F., Wang X.L., and Su Y.H. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus. J. Surg. Oncol. 86 (2004) 99-104
22. Zuo L.F., Lin P.Z., Qi F.Y., Guo J.W., and Liu J.H. Flow cytometric analysis of DNA, telomerase content and multi-gene expression in esophageal epithelial dysplasia, World. J. Gastroenterol. 9 (2003) 2409-2412
23. Abnet C.C., Huppi K., Carrera A., Armistead D., McKenney K., Hu N., et al. Control region mutations and the common deletion are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer 4 (2004) 30-38
24. Jakupciak J.P., Barker P.E., Wang W., Srivastava S., and Atha D.H. Preparation and characterization of candidate reference materials for telomerase assays. Clin. Chem. 51 (2005) 1443-1450
25. O'Connell C.D., and Jakupciak J.P. NIST reference materials for medical testing. In: Coleman W.B., and Tsongalis G.J. (Eds). Encyclopedia of Diagnostic Genomics and Proteomics (2005), Humana Press, New Jersey 243-246
26. Wagner P.D., Maruvada P., and Srivastava S. Molecular diagnostics; a new frontier in cancer prevention. Expert Rev. Mol. Diagn. 4 (2004) 503-511
27. Pepe M.S., Etzioni R., Feng Z., Potter J.D., Thompson M.L., Thornquist M., et al. Phases of biomarker development for early detection of cancer. J. Natl Cancer Inst. 93 (2001) 1054-1061
28. Jakupciak J.P., Wang W., Barker P.E., Srivastava S., and Atha D.H. Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells. J. Mol. Diagn. 6 (2004) 157-165
29. O'Connell C.D., Tulley L., Devaney J., Marino M.A., Jakupciak J.P., and Atha D.H. Renewable standard reference material for the detection of TP53 mutations. Mol. Diagn. 7 (2003) 85-97
30. O'Connell C.D., Atha D.H., Jakupciak J.P., Amos J.A., and Richie K.L. Standardization of PCR amplification for fragile X trinucleotide repeat measurements. Clin. Genet. 61 (2002) 13-20
31. Srivastava S., and Kramer B.S. Early detection cancer research network. Lab. Invest. 80 (2000) 1147-1148
32. Verma M., Dunn B.K., Ross S., Jain P., Wang W., Hayes R., and Umar A. Early detection and risk assessment proceedings and recommendations for the workshop on epigenetics in cancer prevention. Ann. NY Acad. Sci. 983 (2003) 298-319
33. Elmore L.W., Forsythe H.L., Ferreira-Gonzalez A., Garrett C.T., Clark G.M., and Holt S.E. Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent based assay. Diagn. Mol. Path. 11 (2002) 177-185
34. Barker P.E. In: Schimke R.T. (Ed). Isolation of Double Minutes from a Human Tumor Cell Line in 'Gene Amplification' (1982), Cold Spring Harbor, New York 205-212
35. O'Leary T.J. Standardization in immunohistochemistry. Appl. Immunohist. Mol. Morphol. 9 (2001) 1-2
36. Maesawa C., Inaba T., Sato H., Iijima S., Ishida K., Terashima M., et al. A rapid biosensor chip assay for measuring of telomerase activity using surface plasmon resonance. Nucl. Acids Res. 31 (2003) e4-4
37. Hou M., Xu D., Bjorkholm M., and Gruber A. Real-time quantitative telomeric repeat amplification protocol assay fro the detection of telomerase activity. Clin. Chem. 47 (2001) 519-524
38. Wege H., Chui M.S., Le H.T., Tran J.M., and Zern M.A. SYBR green realtime telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucl. Acids Res. 31 (2003) 1-7
39. Botchkina G.I., Kim R.H., Botchina I.L., Kirshenbaum A., Frischer Z., and Adler H.L. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity. Clin. Cancer Res. 11 (2005) 3243-3249
40. Chun L., Ming-Yao W., Ying-Rui L., and Xian-Ying W. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J. Gastroenterol. 9 (2003) 2395-2399
41. Hiyama E., and Hiyama K. Telomerase as tumor marker. Cancer Lett. 194 (2003) 221-233